Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial.

Nature communications·2026
Same author

Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer.

Nature communications·2026
Same author

Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.

Neuro-oncology advances·2026
Same author

First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial.

Nature communications·2026
Same author

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Nature·2026
Same author

An App-Based Remote Patient Monitoring System With Wrist and In-Ear Wearables in Gastrointestinal Oncology: Prospective Feasibility Pilot Study.

JMIR cancer·2025
Same journal

Comparative Effectiveness of AI-Assisted Telerehabilitation, Telerehabilitation, In-Person Care, and Usual Care for Chronic Nonspecific Low Back Pain: Bayesian Network Meta-Analysis.

Journal of medical Internet research·2026
Same journal

Effectiveness of WeChat Public Account Intervention Based on the Information-Motivation-Behavioral Skills Model Among College Students With Internet Addiction: Randomized Controlled Trial.

Journal of medical Internet research·2026
Same journal

Are Traditional Registries Becoming Obsolete in the Modern Digital Health Ecosystem?

Journal of medical Internet research·2026
Same journal

Detecting and Preventing Fraudulent Participation in Qualitative Research: Content Analysis of Two Multisite Studies.

Journal of medical Internet research·2026
Same journal

Patient Perceptions of Artificial Intelligence-Supported Shared Decision-Making in UK Primary Care for Multiple Long-Term Conditions: Qualitative Study.

Journal of medical Internet research·2026
Same journal

Impact of Telemedicine-Enhanced Integrated Management of Gestational Diabetes on Pregnancy Outcomes and Glycemic Control: Real-World Study Using TangMama App.

Journal of medical Internet research·2026
See all related articles

Related Experiment Video

Updated: May 23, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Retrieval Augmented Therapy Suggestion for Molecular Tumor Boards: Algorithmic Development and Validation Study.

Eliza Berman1, Holly Sundberg Malek2, Michael Bitzer3

  • 1Center for Digital Health, University Hospital Tuebingen, Tuebingen, Germany.

Journal of Medical Internet Research
|March 7, 2025
PubMed
Summary
This summary is machine-generated.

Large language models (LLMs) can assist molecular tumor boards (MTBs) by generating treatment recommendations. While LLMs show promise in precision oncology, clinician supervision is essential due to occasional inaccuracies and hallucinations.

Keywords:
LLMsLLaMAMTBaccessibility to careaugmented therapyclinical trialsevidence-basedlarge language modelsmolecular tumormolecular tumor boardoncologypatient careprecision oncologyretrieval augmented generationtreatmenttumor

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.0K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

6.9K

Related Experiment Videos

Last Updated: May 23, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.0K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

6.9K

Area of Science:

  • Oncology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Molecular tumor boards (MTBs) involve extensive manual review for patient treatment recommendations.
  • Large language models (LLMs) offer potential to enhance MTB efficiency, reduce errors, and improve care accessibility in precision oncology.

Purpose of the Study:

  • To evaluate the effectiveness of LLM-generated treatment suggestions for MTB patients.
  • To assess LLMs' capability in providing evidence-based recommendations with PubMed citations.

Main Methods:

  • A retrieval augmented generation pipeline was developed using PubMed data.
  • LLMs were prompted to generate treatment recommendations with PubMed references for a test patient cohort.
  • MTB members manually reviewed the LLM-generated recommendations for accuracy and relevance.

Main Results:

  • 75% of cited articles were correctly sourced from PubMed; 17% were identified as hallucinations.
  • Clinician-evaluated LLM queries showed higher accuracy than automated ones.
  • Clinicians found 25% of LLM responses equivalent to their own and 37.5% as plausible alternatives.

Conclusions:

  • LLM-enhanced retrieval augmented generation can accelerate MTB processes, sometimes yielding clinician-equivalent recommendations.
  • Further research is needed to eliminate hallucinations and ensure consistent LLM performance.
  • LLMs offer a scalable solution for MTB investigations but require significant clinician oversight and cannot fully automate the process.